Education
About Us
Working with TipRanks
Follow Us
Amneal Pharma (AMRX)
:AMRX
Earnings Data
Report Date
Mar 04, 2026Before Open (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
0.19Last Year’s EPS
0.12Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
Amneal Pharmaceuticals demonstrated strong financial performance with growth across key segments and raised guidance, though faced challenges with gross margins and potential uncertainties in partnerships.Company Guidance
Strong Quarterly Performance
Amneal Pharmaceuticals reported Q3 2025 revenues of $785 million and an adjusted EBITDA of $160 million, marking consecutive quarters of growth.
Specialty Segment Success
CREXONT for Parkinson's disease exceeded expectations, with about 80% of prescriptions from IR patients. Peak U.S. sales are expected between $300 million and $500 million.
Biosimilars Market Expansion
Amneal is on track to have 6 marketed biosimilar products by 2027, including a significant opportunity with the Xolair biosimilar.
Increased Financial Guidance
Raised the lower end of adjusted EBITDA guidance by $10 million to a range of $675 million to $685 million and increased adjusted EPS guidance by $0.05.
Debt Refinancing and Leverage Reduction
Completed full debt refinancing, reducing interest costs and extending debt maturities from 2028 to 2032. Reduced net leverage ratio from 3.9x to 3.7x.
AMRX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
AMRX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Oct 30, 2025 | $10.43 | $10.00 | -4.12% |
Aug 05, 2025 | $7.96 | $8.13 | +2.14% |
May 02, 2025 | $7.74 | $7.97 | +2.97% |
Feb 28, 2025 | $8.38 | $8.67 | +3.46% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Amneal Pharma (AMRX) report earnings?
Amneal Pharma (AMRX) is schdueled to report earning on Mar 04, 2026, Before Open (Confirmed).
What is Amneal Pharma (AMRX) earnings time?
Amneal Pharma (AMRX) earnings time is at Mar 04, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is AMRX EPS forecast?
AMRX EPS forecast for the fiscal quarter 2025 (Q4) is 0.19.
